Accuray Incorporated revealed its latest advancements in hardware and software aimed at enhancing the cancer treatment process at ESTRO 2024. The company's newest generation CyberKnife® and Radixact® platforms offer medical professionals the tools needed to expand the efficacy of radiation therapy, aligning with this year's ESTRO theme of bridging the care gap.

ESTRO gathering holds special significance as we commemorate 30 years of collaboration with healthcare practitioners and industry partners, driving the development of cutting-edge technologies that broaden the scope of radiation therapy and enhance patient access to care.

The precision and accuracy of the CyberKnife and Radixact Systems empower our clients to tailor cancer management to each patient's unique journey while efficiently treating more patients than ever before," remarked Suzanne Winter, President, and CEO of Accuray.

With a focus on patient well-being, Accuray prioritizes enhancements that consider the holistic health of individuals throughout their treatment. The solutions showcased at ESTRO represent the culmination of a 30-year legacy of innovation that has redefined standards of care in the radiation therapy field. Attendees are invited to explore Accuray's offerings at booth #480 to learn more.

"Accuray takes pride in our legacy of pioneering advancements in cancer and neuro-radiosurgical technology. The CyberKnife System revolutionized tumor treatment by integrating robotic mobility with real-time imaging, delivering unparalleled precision without the need for uncomfortable stereotactic frames.

TomoTherapy System, which evolved into the Radixact System, we furthered our impact by merging computed tomography (CT) with intensity-modulated radiation therapy (IMRT), enabling clinicians to administer targeted helical radiation therapy tailored to the tumor's complex shape."

Innovations empower medical teams worldwide to treat a wide range of malignant and benign conditions confidently and non-invasively while minimizing damage to healthy tissues. Our collaboration with esteemed physicians and engineers continues to drive advancements in oncology and neuro-radiosurgery, leading to novel solutions that advance and personalize patient care."

Highlights at ESTRO 2024 :

• Radixact System: Featuring a built-in CT scanner for rapid helical imaging, ensuring high-quality images crucial for treatment planning. Consistent image quality and Hounsfield unit uniformity validate their utility in the radiation therapy workflow.

ClearRT™ enhanced imaging on the Radixact System: Facilitating fast, precise, and cost-effective acquisition of high-quality images, ClearRT imaging finds diverse applications in accurate and precise radiation therapy. It aids in rapid and precise patient setup, works seamlessly with Accuray's Synchrony® technology for real-time treatment adaptation, and serves as input for monitoring and adapting treatment plans during the course of therapy with PreciseART® radiotherapy.

• CyberComm™: A novel physics offering designed to significantly reduce commissioning time for the CyberKnife® S7™ System, enabling faster patient treatment initiation.
• Cenos™* (work in progress): Aimed at providing online adaptation of treatment plans for the Radixact System, Cenos™ enables clinical teams to adjust plans as needed between sessions, ensuring clinical objectives are met while offering flexibility to optimize adaptive workflows.

ESTRO 2024 underscores its commitment to developing technologies tailored to the diverse needs of patients, furthering the mission of personalized and effective cancer treatment.


Source: prnewswire.com

Report Abuse